Şunu aradınız:: glucocorticoids (Maltaca - İngilizce)

glucocorticoids
glucocorticoids

glucocorticoids li jittieħdu bis-siringa
injectable glucocorticoids

glucocorticoids (biex jittrattaw allerġiji u infjammazzjonijiet)
glucocorticoids (to treat allergies and inflammation)

avamys jiforma parti mill- grupp ta ’ mediċini msejħa glucocorticoids.
avamys belongs to a group of medicines called glucocorticoids.

fluticasone furoate gsk jiforma parti mill- grupp ta ’ mediċini msejħa glucocorticoids.
fluticasone furoate gsk belongs to a group of medicines called glucocorticoids.

avamys (fluticasone furoate) jagħmel parti minn grupp ta’ mediċini msejħa glucocorticoids.
avamys (fluticasone furoate) belongs to a group of medicines called glucocorticoids.

sejbiet fi studji tossikoloġiċi ġenerali kienu jixbħu lil dawk osservati bi glucocorticoids oħra u huma assoċjati ma’ attività farmakoloġika eżaġerata.
findings in general toxicology studies were similar to those observed with other glucocorticoids and are associated with exaggerated pharmacological activity.

aġenti li jistimulaw it-tirojde, glucocorticoids, derivattivi tal-phenothiazine, chlorpromazine, adrenaline u sympathicomimetics,
thyroid stimulating agents, glucocorticoids, phenothiazine derivatives, chlorpromazine, adrenaline and sympathicomimetics,

thiazides, glucocorticoids, ormoni tat- tirojde u beta- sympathomimetics, ormon tat- tkabbir u danazol.
thiazides, glucocorticoids, thyroid hormones and beta-sympathomimetics, growth hormone and danazol.

f’ studji fuq annimali ntwera li glucocorticoids jistgħu jwasslu għal deformazzjonijiet inklużi cleft palate u żvilupp ritardat ġewwa l-utru.
in animal studies glucocorticoids have been shown to induce malformations including cleft palate and intra-uterine growth retardation.

barra minn hekk, fil- każ li glucocorticoids jiġu revokati, it- tnaqqis fid- doża għandu mnejn irid isir fuq perijodu itwal.
moreover, in case of withdrawal of glucocorticoids progressive dose reduction may have to be performed over a longer period.

l-użu flimkien ta’ ritonavir u fluticasone jew glucocorticoids oħra li jiġu metabolizzati minn cyp3a4 m’huwiex rakkommandat, ħlief jekk il-benefiċji potenzjali tal-kura huma akbar mir-riskju ta’ effetti sistemiċi tal-corticosteroid, li jinkludu is-sindromu cushing (cushing’s syndrome) u soppressjoni adrenali (ara sezzjoni 4.5).
concomitant use of ritonavir and fluticasone or other glucocorticoids that are metabolised by cyp3a4 is not recommended unless the potential benefit of treatment outweighs the risk of systemic corticosteroid effects, including cushing’s syndrome and adrenal suppression (see section 4.5).